Expect Equity LLC Purchases New Holdings in Viemed Healthcare, Inc. $VMD

Expect Equity LLC acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 212,721 shares of the company’s stock, valued at approximately $2,425,000. Viemed Healthcare accounts for 1.6% of Expect Equity LLC’s investment portfolio, making the stock its 27th largest position. Expect Equity LLC owned about 0.56% of Viemed Healthcare at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State of Alaska Department of Revenue purchased a new stake in shares of Viemed Healthcare in the fourth quarter valued at $25,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Viemed Healthcare in the 4th quarter valued at $46,000. Quarry LP acquired a new stake in shares of Viemed Healthcare in the third quarter worth about $48,000. Globeflex Capital L P acquired a new stake in shares of Viemed Healthcare in the second quarter worth about $86,000. Finally, AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 1st quarter worth about $90,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Trading Up 0.1%

Viemed Healthcare stock opened at $9.10 on Wednesday. Viemed Healthcare, Inc. has a 52 week low of $6.05 and a 52 week high of $12.61. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. The firm has a market capitalization of $346.62 million, a PE ratio of 25.28 and a beta of 1.10. The business’s 50-day simple moving average is $10.92 and its 200-day simple moving average is $9.89.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). The business had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Equities research analysts forecast that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current year.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider William Frazier sold 10,000 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 20.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Weiss Ratings lowered Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. Freedom Capital lowered Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Wall Street Zen cut Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Finally, Barrington Research assumed coverage on Viemed Healthcare in a report on Monday. They set an “outperform” rating and a $14.00 price target on the stock. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Viemed Healthcare currently has a consensus rating of “Hold” and a consensus price target of $14.00.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.